APPLICATION
ANDA214071
TYPE
ANDA
ORIGINAL APPROVAL
2022-06-09
LATEST ACTION
2023-03-27
ROUTE
ORAL
DOSAGE FORM
SUSPENSION/DROPS
MARKETING STATUS
Discontinued
Products
IBUPROFENDiscontinued
IBUPROFEN 50MG/1.25ML · SUSPENSION/DROPS · ORAL
Approval history
2023-03-27Manufacturing (CMC) · Supplement 1 · unknownAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.